These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4301383)

  • 41. Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates.
    Kolibab K; Derrick SC; Morris SL
    J Clin Microbiol; 2011 Jun; 49(6):2380-1. PubMed ID: 21508153
    [No Abstract]   [Full Text] [Related]  

  • 42. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 43. [Isolation of mutants resistant to antituberculous drugs in wild strains of M. bovis].
    de Kantor IN; Lesslie IW
    Medicina (B Aires); 1974; 34(3):244-8. PubMed ID: 4212693
    [No Abstract]   [Full Text] [Related]  

  • 44. The 7H11 medium for the cultivation of mycobacteria.
    Cohn ML; Waggoner RF; McClatchy JK
    Am Rev Respir Dis; 1968 Aug; 98(2):295-6. PubMed ID: 4299186
    [No Abstract]   [Full Text] [Related]  

  • 45. Mycobacterium resistance to antimycobacterial reagent.
    Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
    Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
    Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [On some aspects of antimycobacterial activity in vitro of cycloserine and terizidone].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(2):105-15. PubMed ID: 4981145
    [No Abstract]   [Full Text] [Related]  

  • 48. [Bacteriostatic activity of preparations of the 2d series and criteria of the resistance to them].
    Mkrtchian SV; Afanas'eva IuP
    Probl Tuberk; 1967; 45(8):70-5. PubMed ID: 4303640
    [No Abstract]   [Full Text] [Related]  

  • 49. [Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice].
    Zueva VS; Solov'ev VN
    Antibiotiki; 1968 Apr; 13(4):355-9. PubMed ID: 4970747
    [No Abstract]   [Full Text] [Related]  

  • 50. [Observations of the activity of capreomycin, cicloserine, kanamycin and streptomycin to clinical isolates of Mycobacterium tubercolosis].
    De Stasio A; Puccini G
    Antibiotica; 1968 Dec; 6(4):358-62. PubMed ID: 4984521
    [No Abstract]   [Full Text] [Related]  

  • 51. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J; Bönicke R
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the problem of the pathogenicity of resistant and atypical mycobacteria in relation to rabbits and chickens].
    Beliakova OI; Shlapak PT; Korzh BA
    Probl Tuberk; 1968; 46(3):56-60. PubMed ID: 4971316
    [No Abstract]   [Full Text] [Related]  

  • 53. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 54. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract]   [Full Text] [Related]  

  • 55. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
    Iavors'ka HV; Puhachevs'ka LP
    Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 57. [The activity of nicotinic acid hydroxylase and pyrocatechase in chemosensitive mycobacteria and their chemoresistant variants].
    Lippelt CH; Bönicke R
    Zentralbl Bakteriol Orig; 1968; 209(1):62-71. PubMed ID: 4317775
    [No Abstract]   [Full Text] [Related]  

  • 58. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T; Mizuguchi Y; Suga K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract]   [Full Text] [Related]  

  • 59. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 60. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.